BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33074595)

  • 1. MiR-133a acts as a tumor suppressor in lung cancer progression by regulating the LASP1 and TGF-β/Smad3 signaling pathway.
    Shen Y; Yang Y; Li Y
    Thorac Cancer; 2020 Dec; 11(12):3473-3481. PubMed ID: 33074595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway.
    Sun L; Guo Z; Sun J; Li J; Dong Z; Zhang Y; Chen J; Kan Q; Yu Z
    Biomed Pharmacother; 2018 Nov; 107():168-176. PubMed ID: 30086463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1.
    Shen Q; Sun Y; Xu S
    Respir Res; 2020 Sep; 21(1):235. PubMed ID: 32938459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0072088 knockdown contributes to cisplatin sensitivity and inhibits tumor progression by miR-944/LASP1 axis in non-small cell lung cancer.
    Zhang L; Wu Y; Hou C; Li F
    J Gene Med; 2022 May; 24(5):e3414. PubMed ID: 35106879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
    Sun W; Zu S; Shao G; Wang W; Gong F
    J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.
    Shi Y; Wang X; Xu Z; He Y; Guo C; He L; Huan C; Cai C; Huang J; Zhang J; Li Y; Zeng C; Zhang X; Wang L; Ke Y; Cheng H
    J Biol Chem; 2020 Oct; 295(40):13798-13811. PubMed ID: 32737199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells.
    Li H; Xiang Z; Liu Y; Xu B; Tang J
    Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-
    Xue Q; Jiang H; Wang J; Wei D
    Can Respir J; 2021; 2021():5277409. PubMed ID: 34912481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
    Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
    IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
    Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
    J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.